[{"address1": "1200 Brickell Avenue", "address2": "Suite 1950 #1183", "city": "Miami", "state": "FL", "zip": "32183", "country": "United States", "phone": "786-432-9792", "website": "https://mirapharmaceuticals.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Erez  Aminov", "age": 46, "title": "CEO & Chairman", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 626193, "exercisedValue": 0, "unexercisedValue": 113700}, {"maxAge": 1, "name": "Mr. Alan  Weichselbaum CPA, M.B.A.", "age": 59, "title": "Chief Financial Officer", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Itzchak  Angel Ph.D.", "title": "Chief Scientific Advisor", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.3, "open": 1.32, "dayLow": 1.3, "dayHigh": 1.335, "regularMarketPreviousClose": 1.3, "regularMarketOpen": 1.32, "regularMarketDayLow": 1.3, "regularMarketDayHigh": 1.335, "payoutRatio": 0.0, "beta": 1.772, "forwardPE": -2.6938777, "volume": 136036, "regularMarketVolume": 136036, "averageVolume": 1529180, "averageVolume10days": 1422570, "averageDailyVolume10Day": 1422570, "bid": 1.29, "ask": 1.34, "bidSize": 3, "askSize": 3, "marketCap": 25171498, "fiftyTwoWeekLow": 0.73, "fiftyTwoWeekHigh": 2.56, "allTimeHigh": 7.98, "allTimeLow": 0.51, "fiftyDayAverage": 1.4712, "twoHundredDayAverage": 1.24044, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 24441020, "profitMargins": 0.0, "floatShares": 14803700, "sharesOutstanding": 19069315, "sharesShort": 194669, "sharesShortPriorMonth": 264242, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.010199999, "heldPercentInsiders": 0.22368999, "heldPercentInstitutions": 0.05061, "shortRatio": 0.3, "shortPercentOfFloat": 0.0138, "impliedSharesOutstanding": 19069315, "bookValue": 0.033, "priceToBook": 40.0, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -7765054, "trailingEps": -0.47, "forwardEps": -0.49, "52WeekChange": 0.015384674, "SandP52WeekChange": 0.1529237, "quoteType": "EQUITY", "currentPrice": 1.32, "targetHighPrice": 17.75, "targetLowPrice": 17.75, "targetMeanPrice": 17.75, "targetMedianPrice": 17.75, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 730475, "totalCashPerShare": 0.038, "totalDebt": 0, "quickRatio": 2.447, "currentRatio": 2.791, "returnOnAssets": -2.53313, "returnOnEquity": -5.5686903, "freeCashflow": -3230965, "operatingCashflow": -6076819, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MIRA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "postMarketChangePercent": 0.0, "postMarketPrice": 1.32, "postMarketChange": 0.0, "regularMarketChange": 0.0200001, "regularMarketDayRange": "1.3 - 1.335", "fullExchangeName": "NasdaqCM", "corporateActions": [], "postMarketTime": 1758931142, "regularMarketTime": 1758916801, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1691069400000, "averageDailyVolume3Month": 1529180, "fiftyTwoWeekLowChange": 0.59000003, "fiftyTwoWeekLowChangePercent": 0.8082192, "fiftyTwoWeekRange": "0.73 - 2.56", "fiftyTwoWeekHighChange": -1.2399999, "fiftyTwoWeekHighChangePercent": -0.48437497, "fiftyTwoWeekChangePercent": 1.5384674, "epsTrailingTwelveMonths": -0.47, "epsForward": -0.49, "epsCurrentYear": -0.3, "priceEpsCurrentYear": -4.4, "fiftyDayAverageChange": -0.15119994, "fiftyDayAverageChangePercent": -0.102773204, "twoHundredDayAverageChange": 0.07956004, "twoHundredDayAverageChangePercent": 0.06413856, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-08-03", "cryptoTradeable": false, "regularMarketChangePercent": 1.53847, "regularMarketPrice": 1.32, "shortName": "MIRA Pharmaceuticals, Inc.", "longName": "MIRA Pharmaceuticals, Inc.", "exchange": "NCM", "messageBoardId": "finmb_1793899557", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "MIRA Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-09-27"}]